Three-Stage Design for Drug Screening Trials Based on Continuous Endpoints
碩士 === 國立成功大學 === 統計學系碩博士班 === 100 === Due to the development of target therapy, the evaluation in cancer clinical trials will change. Different with drugs of chemotherapy, the drug of target therapy belong to the cytostatic drugs and the main goal is to stopping the growth of tumor for a period of...
Main Authors: | Shan-YunHuang, 黃山耘 |
---|---|
Other Authors: | Mi-Chia Ma |
Format: | Others |
Language: | en_US |
Published: |
2012
|
Online Access: | http://ndltd.ncl.edu.tw/handle/19133975740345468628 |
Similar Items
-
Bayesian Two-Stage Design for Drug Screening Trials with Switching Hypothesis Tests based on Continuous Endpoints
by: NanSun, et al.
Published: (2017) -
Bayesian Two-Stage Designs for Phase II Clinical Trials with Continuous Endpoints
by: Chen, Szu-Hsuan, et al.
Published: (2013) -
A Two-Stage Design for Stratified Phase II Clinical Trials with Continuous Endpoints
by: Zai-Jyun, Chen, et al.
Published: (2013) -
An Alternative Phase II/III Design in Clinical Trials for Continuous Endpoint
by: Liu, Chia-Pei, et al.
Published: (2010) -
A Phase II/III Adaptive Design for Evaluation of Drugs Efficacy Based on Continuous Endpoints
by: Wong-Shian Huang, et al.
Published: (2008)